Alyeska Investment Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
+115,866
| New | +$1.31M | ﹤0.01% | 491 |
|
|
2024
Q4 | – | Sell |
-1,000,000
| Closed | -$11.5M | – | 649 |
|
|
2024
Q3 | $11.5M | Hold |
1,000,000
| – | – | 0.06% | 283 |
|
|
2024
Q2 | $10.6M | Buy |
+1,000,000
| New | +$10.6M | 0.06% | 261 |
|
|
2023
Q4 | – | Sell |
-282,414
| Closed | -$3.3M | – | 582 |
|
|
2023
Q3 | $3.3M | Buy |
+282,414
| New | +$3.3M | 0.02% | 354 |
|
|
2023
Q2 | – | Sell |
-561,612
| Closed | -$4.14M | – | 570 |
|
|
2023
Q1 | $4.14M | Buy |
561,612
+392,812
| +233% | +$2.9M | 0.04% | 309 |
|
|
2022
Q4 | $1.35M | Buy |
+168,800
| New | +$1.35M | 0.01% | 341 |
|